15 hrs ago
Resmed Is Still A Strong Profit Grower With New Product Launches Expected Soon
Resmed maintains its strong track record for profits and net gearing is -34.4% due to strong cash position more than 3 times long-term debt.
Tue Aug 19, 2014
NBC San Diego
New Devices from Kearny Mesa's ResMed
ResMed Inc. has released its new sleep apnea therapy device that will use patient data and communication software to help health care providers monitor and analyze their patients' conditions.
Mon Aug 11, 2014
A New Beginning: ResMed's New Air Solutions Connected Care Platform...
The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
A New Beginning: ResMed's New Air Solutions Connected Care...
Platform Maximizes the Power of Data from Diagnosis to Patient Engagement for the Benefit of All Stakeholders in the Care Continuum /PRNewswire/ -- ResMed today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum.
Tue Aug 05, 2014
ResMed COO Robert Andrew Douglas Sells 8,000 Shares
ResMed COO Robert Andrew Douglas sold 8,000 shares of the stock on the open market in a transaction that occurred on Friday, August 1st.
Fri Aug 01, 2014
ResMed Sees Unusually-High Trading Volume Following Dividend Announcement
ResMed saw unusually-high trading volume on Friday following a dividend announcement from the company, AmericanBankingNews.com reports.
Sydney Morning Herald
Markets Live: Shares go downhill faster
But a lack of affordability at the lower end of the market meant the number of homes selling is still below peak levels .
Thu Jul 31, 2014
Sydney Morning Herald
Resmed's poor US result caps a tough year
ResMed has reported a fourth quarter sales slump in the key United States market that has capped off a tough year as the medical device maker battles falling prices and hesitant customers.
ResMed's (RMD) CEO Michael Farrell on Q4 2014 Results - Earnings Call Transcript
Welcome to the Fourth Quarter 2014 ResMed Earnings Conference Call. My name is Larissa, and I'll be your operator for today's call.
ResMed (RMD) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS
ResMed issued its quarterly earnings data on Thursday. The company reported $0.64 earnings per share for the quarter, missing the analysts' consensus estimate of $0.66 by $0.02, AmericanBankingNews.com reports.